Page last updated: 2024-11-04

temozolomide and Cancer of Parathyroid

temozolomide has been researched along with Cancer of Parathyroid in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We report here a rare case of a young male patient presenting with a Multiple Endocrine Neoplasia Type 1 - prolactin-secreting pituitary carcinoma, controlled long-term after temozolomide withdrawal."7.78Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment. ( Barlier, A; Barrie, M; Brue, T; Castinetti, F; Conte-Devolx, B; Dufour, H; Morange, I; Philippon, M; Taieb, D, 2012)
"We report here a rare case of a young male patient presenting with a Multiple Endocrine Neoplasia Type 1 - prolactin-secreting pituitary carcinoma, controlled long-term after temozolomide withdrawal."3.78Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment. ( Barlier, A; Barrie, M; Brue, T; Castinetti, F; Conte-Devolx, B; Dufour, H; Morange, I; Philippon, M; Taieb, D, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Philippon, M1
Morange, I1
Barrie, M1
Barlier, A1
Taieb, D1
Dufour, H1
Conte-Devolx, B1
Brue, T1
Castinetti, F1

Other Studies

1 other study available for temozolomide and Cancer of Parathyroid

ArticleYear
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
    Annales d'endocrinologie, 2012, Volume: 73, Issue:3

    Topics: Adult; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Dacarbazine

2012